Major congenital malformations in offspring of women with chronic diseases—impact of the disease or the treatment?

[1]  L. Husemoen,et al.  Risk of Major Congenital Malformations or Perinatal or Neonatal Death With Insulin Detemir Versus Other Basal Insulins in Pregnant Women With Preexisting Diabetes: The Real-World EVOLVE Study , 2021, Diabetes Care.

[2]  G. Tomlinson,et al.  Increased risk of major congenital malformations in early pregnancy use of angiotensin‐converting‐enzyme inhibitors and angiotensin‐receptor‐blockers: a meta‐analysis , 2021, Diabetes/Metabolism Research and Reviews.

[3]  A. Tabor,et al.  Degree of pregnancy planning and recommended pregnancy planning behavior among women with and without chronic medical conditions – A large hospital‐based cross‐sectional study , 2020, Acta obstetricia et gynecologica Scandinavica.

[4]  S. Hernández-Díaz,et al.  Perinatal Outcomes Associated with Maternal Asthma and its Severity and Control during Pregnancy. , 2020, The journal of allergy and clinical immunology. In practice.

[5]  K. Sward,et al.  Multi-morbidity and Highly Effective Contraception in Reproductive-Age Women in the US Intermountain West: a Retrospective Cohort Study , 2019, Journal of General Internal Medicine.

[6]  P. Damm,et al.  Congenital heart defects in offspring of women with Type 2 diabetes - a systematic review. , 2019, Danish medical journal.

[7]  P. Damm,et al.  The prevalence of congenital malformations is still higher in pregnant women with pregestational diabetes despite near-normal HbA1c: a literature review , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[8]  H. Abenhaim,et al.  Pregnancy outcomes among women with asthma , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[9]  M. Gissler,et al.  Pregnancy and Perinatal Outcome Among Hypothyroid Mothers: A Population-Based Cohort Study. , 2019, Thyroid : official journal of the American Thyroid Association.

[10]  Matthew M Davis,et al.  Disparities in Chronic Conditions Among Women Hospitalized for Delivery in the United States, 2005-2014. , 2017, Obstetrics and gynecology.

[11]  S. Carmichael,et al.  Thyroid Medication Use and Birth Defects in the National Birth Defects Prevention Study. , 2017, Birth defects research.

[12]  L. Blais,et al.  The Impact of Different Case Ascertainment Definitions on the Prevalence of Major Congenital Malformations and their Association with Asthma During Pregnancy , 2017, Maternal and Child Health Journal.

[13]  A. Bérard,et al.  Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort , 2017, BMJ Open.

[14]  B. Nørgård,et al.  Prevalence of maternal chronic diseases during pregnancy – a nationwide population based study from 1989 to 2013 , 2016, Acta obstetricia et gynecologica Scandinavica.

[15]  E. Garne,et al.  Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy – a cohort linkage study , 2016, BJOG : an international journal of obstetrics and gynaecology.

[16]  S. Hernández-Díaz,et al.  Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study. , 2015, American journal of obstetrics and gynecology.

[17]  S. Vohra,et al.  Maternal hypothyroidism may be associated with CHD in offspring , 2014, Cardiology in the Young.

[18]  L. Smeeth,et al.  Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study , 2014, BJOG : an international journal of obstetrics and gynaecology.

[19]  W. Hoffmann,et al.  Chronic diseases in pregnant women: prevalence and birth outcomes based on the SNiP-study , 2014, BMC Pregnancy and Childbirth.

[20]  A. Aschengrau,et al.  Asthma Drugs and the Risk of Congenital Anomalies , 2013, Pharmacotherapy.

[21]  Shoaib Afzal,et al.  Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study , 2012, BMJ Open.

[22]  G. Koren,et al.  Pregnancy Outcome After Exposure to Antidepressants and the Role of Maternal Depression: Results From the Norwegian Mother and Child Cohort Study , 2012, Journal of clinical psychopharmacology.

[23]  S. Andrade,et al.  Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study , 2011, BMJ : British Medical Journal.

[24]  F. Tao,et al.  Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. , 2011, The Journal of clinical endocrinology and metabolism.

[25]  G. Koren,et al.  Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers , 2011, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[26]  M. Clementi,et al.  Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers. , 2011, Reproductive toxicology.

[27]  A. Czeizel,et al.  Chronic hypertension with related drug treatment of pregnant women and congenital abnormalities in their offspring: a population-based study , 2011, Hypertension Research.

[28]  L. Blais,et al.  Effect of maternal asthma on the risk of specific congenital malformations: A population-based cohort study. , 2010, Birth defects research. Part A, Clinical and molecular teratology.

[29]  J. Olsen,et al.  Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study , 2009, BMJ : British Medical Journal.

[30]  Sharmila Chatterjee,et al.  Prevalence of chronic illness in pregnancy, access to care, and health care costs: implications for interconception care. , 2008, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[31]  B. Källén,et al.  Maternal use of thyroid hormones in pregnancy and neonatal outcome , 2008, Acta obstetricia et gynecologica Scandinavica.

[32]  A. Bérard,et al.  Duration of antidepressant use during pregnancy and risk of major congenital malformations , 2008, British Journal of Psychiatry.

[33]  S. Hernández-Díaz,et al.  Major congenital malformations after first-trimester exposure to ACE inhibitors. , 2006, The New England journal of medicine.

[34]  C. Kimmel,et al.  Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment , 2003, Pharmacoepidemiology and drug safety.

[35]  B. Källén,et al.  Maternal drug use in early pregnancy and infant cardiovascular defect. , 2003, Reproductive toxicology.

[36]  T. Prout.  Thyroid disease in pregnancy. , 1966, American journal of obstetrics and gynecology.